Konstantinos Xanthopoulos

Associate professor of Pharmacology

Aristotle University of Thessaloniki

Greece

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Konstantinos Xanthopoulos is an Associate Professor of Pharmacology at Aristotle University of Thessaloniki, Greece. His research focuses on various aspects of pharmacology, including cancer, metabolic liver diseases, neurodegenerative disorders, and prion diseases, as evidenced by his recent publications. Notable studies include investigations into the role of CYLD in lymphoma and the preventive effects of empagliflozin in metabolic dysfunction.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (4)

George Mosialos

Professor

Aristotle University of Thessaloniki

GREECE

View details

Inga Zerr

GERMANY

View details

EVANGELIA MAKRI

Aristotle University of Thessaloniki

GREECE

View details

Vasilios C. Constantinides

National and Kapodistrian University of Athens

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Konstantinos Xanthopoulos

Research Interests

Contact this professor

About

Articles (10)

Loss of CYLD promotes splenic marginal zone lymphoma.

SIMOA Diagnostics on Alzheimer’s Disease and Frontotemporal Dementia

Limited preventive effects of empagliflozin against metabolic dysfunction-associated steatotic liver disease in a mouse model of fast food diet.

RNA editing regulates glutamatergic synapses in the frontal cortex of a molecular subtype of Amyotrophic Lateral Sclerosis.

A Comparison of RML Prion Inactivation Efficiency by Heterogeneous and Homogeneous Photocatalysis

Animal studies of sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease.

Αnti-prion effects of anthocyanins.

Partial validation of a six-month high-fat diet and fructose-glucose drink combination as a mouse model of nonalcoholic fatty liver disease.

Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency

Intranuclear inclusions of polyQ-expanded ATXN1 sequester RNA molecules.

Collaborators (4)

George Mosialos

Inga Zerr

EVANGELIA MAKRI

Vasilios C. Constantinides

Make your next move.